hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML [Opdivo Qvantig]
RxNorm concept 2700801, branded drug component (sbdc).
- RxCUI
- 2700801
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2700801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- 5 ML hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML Injection [Opdivo Qvantig] (SBD, constitutes)
- 2.5 ML hyaluronidase-nvhy 2000 UNT/ML / nivolumab-nvhy 120 MG/ML Injection [Opdivo Qvantig] (SBD, constitutes)
- Opdivo Qvantig (BN, has ingredient)
- hyaluronidase-nvhy 2000 UNT/ML (SCDC, tradename of)
- nivolumab-nvhy 120 MG/ML (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2700801 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2700801 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2700801. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.